This page shows Dror Ortho-Design (DROR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Dror Ortho-Design passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, Dror Ortho-Design generates $0.81 in operating cash flow (-$2.1M OCF vs -$2.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Dror Ortho-Design's EBITDA was -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 57.5% from the prior year.
Dror Ortho-Design reported -$2.5M in net income in fiscal year 2025. This represents an increase of 55.9% from the prior year.
Dror Ortho-Design earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Cash & Balance Sheet
Dror Ortho-Design generated -$2.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.6% from the prior year.
Dror Ortho-Design held $229K in cash against $0 in long-term debt as of fiscal year 2025.
Dror Ortho-Design had 957M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
Dror Ortho-Design invested $816K in research and development in fiscal year 2025. This represents a decrease of 47.0% from the prior year.
Dror Ortho-Design invested $966 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.3% from the prior year.
DROR Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $151K-53.3% | $324K+35.3% | $240K | N/A | $451K+15.9% | $389K+4.2% | $374K |
| SG&A Expenses | N/A | $318K-18.7% | $391K+24.8% | $314K | N/A | $308K-7.7% | $333K-13.6% | $386K |
| Operating Income | N/A | -$470K+35.8% | -$732K-26.9% | -$576K | N/A | -$1.3M+13.0% | -$1.5M-15.5% | -$1.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | -$654K+13.9% | -$759K-31.8% | -$576K | N/A | -$1.8M-21.2% | -$1.5M-15.2% | -$1.3M |
| EPS (Diluted) | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 |
DROR Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $259K-4.5% | $271K+104.5% | $133K-70.1% | $443K-33.1% | $663K-47.7% | $1.3M-34.0% | $1.9M-28.1% | $2.7M |
| Current Assets | $239K-4.8% | $251K+126.1% | $111K-73.6% | $420K-34.2% | $639K-48.6% | $1.2M-34.4% | $1.9M-28.6% | $2.7M |
| Cash & Equivalents | $229K-4.9% | $240K+272.8% | $64K-81.6% | $350K-36.3% | $549K-51.9% | $1.1M-37.7% | $1.8M-28.1% | $2.6M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $3.1M+21.0% | $2.6M+44.1% | $1.8M+31.7% | $1.4M+32.4% | $1.0M+15.4% | $893K+239.6% | $263K-7.2% | $283K |
| Current Liabilities | $3.0M+22.1% | $2.4M+47.7% | $1.6M+33.2% | $1.2M+35.7% | $907K+2.1% | $888K+244.2% | $258K-7.3% | $278K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$2.9M-24.0% | -$2.3M-39.3% | -$1.7M-80.7% | -$921K-150.3% | -$368K-198.3% | $374K-77.4% | $1.7M-30.6% | $2.4M |
| Retained Earnings | -$22.1M-2.6% | -$21.5M-3.1% | -$20.8M0.0% | -$20.8M-6.8% | -$19.5M-6.2% | -$18.4M-11.0% | -$16.5M-10.0% | -$15.0M |
DROR Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$649K-53.0% | -$424K+12.6% | -$485K+2.8% | -$500K+11.3% | -$563K+18.5% | -$691K+2.2% | -$706K+9.6% | -$781K |
| Capital Expenditures | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $9K-45.6% | $17K |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$563K+18.5% | -$691K+3.4% | -$716K+10.3% | -$798K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | $0 | $0+100.0% | -$9K+45.6% | -$17K |
| Financing Cash Flow | $650K+8.3% | $600K+200.0% | $200K-33.3% | $300K | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
DROR Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | -487.9%-397.0pp | -90.9%-36.1pp | -54.7% |
| Return on Assets | N/A | -241.0%+331.6pp | -572.6%-442.6pp | -130.0% | N/A | -144.1%-65.7pp | -78.4%-29.5pp | -48.9% |
| Current Ratio | 0.08-0.0 | 0.10+0.0 | 0.07-0.3 | 0.34-0.4 | 0.70-0.7 | 1.40-5.9 | 7.35-2.2 | 9.55 |
| Debt-to-Equity | -1.09+0.0 | -1.12-0.0 | -1.08+0.4 | -1.48+1.3 | -2.80-5.2 | 2.38+2.2 | 0.16+0.0 | 0.12 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Dror Ortho-Design profitable?
No, Dror Ortho-Design (DROR) reported a net income of -$2.5M in fiscal year 2025.
What is Dror Ortho-Design's EBITDA?
Dror Ortho-Design (DROR) had EBITDA of -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Dror Ortho-Design's free cash flow?
Dror Ortho-Design (DROR) generated -$2.1M in free cash flow during fiscal year 2025. This represents a 25.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Dror Ortho-Design's operating cash flow?
Dror Ortho-Design (DROR) generated -$2.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Dror Ortho-Design's total assets?
Dror Ortho-Design (DROR) had $259K in total assets as of fiscal year 2025, including both current and long-term assets.
What are Dror Ortho-Design's capital expenditures?
Dror Ortho-Design (DROR) invested $966 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Dror Ortho-Design spend on research and development?
Dror Ortho-Design (DROR) invested $816K in research and development during fiscal year 2025.
What is Dror Ortho-Design's current ratio?
Dror Ortho-Design (DROR) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Dror Ortho-Design's debt-to-equity ratio?
Dror Ortho-Design (DROR) had a debt-to-equity ratio of -1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Dror Ortho-Design's return on assets (ROA)?
Dror Ortho-Design (DROR) had a return on assets of -982.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Dror Ortho-Design's cash runway?
Based on fiscal year 2025 data, Dror Ortho-Design (DROR) had $229K in cash against an annual operating cash burn of $2.1M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Dror Ortho-Design's debt-to-equity ratio negative or unusual?
Dror Ortho-Design (DROR) has negative shareholder equity of -$2.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Dror Ortho-Design's Piotroski F-Score?
Dror Ortho-Design (DROR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Dror Ortho-Design's earnings high quality?
Dror Ortho-Design (DROR) has an earnings quality ratio of 0.81x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.